PBPH

PBPH
About Portfolio Building Block World Pharma and Biotech Index ETF
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a...
About Portfolio Building Block World Pharma and Biotech Index ETF
The Portfolio Building Block World Pharma and Biotech Index ETF seeks to provide investors with targeted exposure to the global pharmaceutical and biotechnology industries, two of the most dynamic and innovation-driven sectors in healthcare. The fund seeks to replicate the performance of the BITA Global Pharma and Biotech Select Index, which tracks companies in developed markets that derive a...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 15.28% | 108.94K | $122.59M |
JNJ | Johnson & Johnson | 8.83% | 310.67K | $70.89M |
ABBV | AbbVie Inc. | 6.39% | 227.94K | $51.27M |
MRK | Merck & Co., Inc. | 4.77% | 318.54K | $38.31M |
AMGN | Amgen Inc. | 4.27% | 99.03K | $34.23M |
GILD | Gilead Sciences, Inc. | 4.10% | 254.49K | $32.88M |
BMY | Bristol-Myers Squibb Company | 2.97% | 420.54K | $23.80M |
VRTX | Vertex Pharmaceuticals Incorporated | 2.86% | 52.01K | $22.97M |
SNY | Sanofi | 2.47% | 223.00K | $19.83M |
REGN | Regeneron Pharmaceuticals, Inc. | 1.64% | 20.97K | $13.18M |
ARGX | argenx SE | 1.33% | 12.58K | $10.66M |
ALNY | Alnylam Pharmaceuticals, Inc. | 1.02% | 26.98K | $8.19M |
ZTS | Zoetis Inc. | 0.86% | 86.47K | $6.88M |
NTRA | Natera, Inc. | 0.75% | 27.21K | $6.04M |
BIIB | Biogen Inc. | 0.72% | 29.47K | $5.79M |
RVMD | Revolution Medicines, Inc. | 0.65% | 33.71K | $5.25M |
ILMN | Illumina, Inc. | 0.65% | 30.81K | $5.18M |
HLN | Haleon plc | 0.63% | 1.14M | $5.07M |
UTHR | United Therapeutics Corporation | 0.60% | 8.84K | $4.84M |
INSM | Insmed Incorporated | 0.56% | 42.78K | $4.49M |
ASSET ALLOCATION BY REGION
ASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
JNJ
Johnson & Johnson
ABBV
AbbVie Inc.
MRK
Merck & Co., Inc.
AMGN
Amgen Inc.
GILD
Gilead Sciences, Inc.
BMY
Bristol-Myers Squibb Company
VRTX
Vertex Pharmaceuticals Incorporated
SNY
Sanofi
REGN
Regeneron Pharmaceuticals, Inc.
ARGX
argenx SE
ALNY
Alnylam Pharmaceuticals, Inc.
ZTS
Zoetis Inc.
NTRA
Natera, Inc.
BIIB
Biogen Inc.
RVMD
Revolution Medicines, Inc.
ILMN
Illumina, Inc.
HLN
Haleon plc
UTHR
United Therapeutics Corporation
INSM
Insmed Incorporated
